Helena Iznardo, Esther Roé, Esther Serra-Baldrich, & Lluís Puig. (2023). Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis. MDPI AG.
Chicago Style (17th ed.) CitationHelena Iznardo, Esther Roé, Esther Serra-Baldrich, and Lluís Puig. Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis. MDPI AG, 2023.
MLA (9th ed.) CitationHelena Iznardo, et al. Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.